Step 1 - Initial treatment period
The initial treatment period lasts for 10 weeks and is split into 2 parts:
- The activation phase (3 weeks) - Flow is used for 30 minutes a day, 5 days a week to activate the neural network.
- The strengthening phase (7 weeks) - Flow is used for 30 minutes a day, 2 days a week to support the progress made in the activation phase.
A large randomised controlled research study as well as Flow's real-world data (based on over 16,000 Flow users) indicate that 90% of the improvements people see with the Flow treatment usually occur within the first 10 weeks.
Step 2 - Evaluate
After 10 weeks of treatment, use the following 3 scenarios to evaluate how to continue with Flow:
Step 3 - Continue for 6-12 months
According to current scientific evidence on depression relapse, everyone has a heightened risk of relapsing during the first 6 to 12 months following treatment. During that period, the brain is prone to falling back into depressive thinking and functioning.
Unfortunately, depression has a habit of coming back.
This is why it's so important to continue using Flow for at least 6 to 12 months after your initial 10 week treatment period.
Treatment length depends on your risk of relapse
Unfortunately, everyone is at risk of depression relapse. Some are low risk, whereas others are high risk.
After the initial 10 weeks, those at low risk should use Flow for at least 6 months, whereas those at high risk should use Flow for at least 12 months.
If you recognise any of the following factors, you may be high risk:
- You have experienced childhood maltreatment (such as physical, emotional or sexual abuse, physical or emotional neglect, family conflict or violence).
- You experience lingering symptoms from your last depressive episode (you were never fully recovered).
- You have a history of prior depressive episodes.
Flow is safe to use long-term
There are no health risks associated with the technology used in the Flow headset (tDCS). On the contrary, research participants have used the same tDCS technology for 6 consecutive months without any changes in side effects, which is a good indication of long-term safety1.
In addition, Flow’s long-term recommendations have been reviewed by a board of distinguished scientists, including Professor of Psychiatry at King’s College London, Allan Young.
However, research is performed on groups of people not individuals. So, we can never perfectly predict how the treatment will affect you as a unique individual with your unique health profile.